Reader TTS

Characterization of the heterogeneity in the glycosylation of biotherapeutics is crucial for drug development but challenging. Now, an approach allows the rapid analysis of the glycosylation

of intact glycoproteins, without prior processing or separation, enabling the study of glycan composition and quality assessment of any glycoprotein drug. Access through your institution

Buy or subscribe This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Access Nature and 54 other Nature Portfolio journals

Get Nature+, our best-value online-access subscription $32.99 / 30 days cancel any time Learn more Subscribe to this journal Receive 12 print issues and online access $259.00 per year only

$21.58 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout

ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support REFERENCES * Rogstad, S. et al. _J. Am. Soc. Mass Spectrom._ 28,

786–794 (2017). Article  CAS  PubMed  Google Scholar  * O’Flaherty, R., Trbojević-Akmačić, I., Greville, G., Rudd, P. M. & Lauc, G. _Expert Rev. Proteom._ 15, 13–29 (2018). Article 

Google Scholar  * Yehuda, S. & Padler-Karavani, V. _Front. Immunol._ 11, 21 (2020). Article  CAS  PubMed  PubMed Central  Google Scholar  * Trbojević-Akmačić, I. et al. _Chem. Rev._ 122,

15865–15913 (2022). Article  PubMed  PubMed Central  Google Scholar  * Mastrangeli, R., Audino, M. C., Palinsky, W., Broly, H. & Bierau, H. _Trends Pharmacol. Sci._ 42, 943–956 (2021).

Article  CAS  PubMed  Google Scholar  * Wu, D. & Robinson, C. V. _Curr. Opin. Struct. Biol._ 74, 102351 (2022). Article  CAS  PubMed  Google Scholar  * Pralow, A., Cajic, S., Alagesan,

K., Kolarich, D. & Rapp, E. in _Advances in Glycobiotechnology_ 1st edn (eds Rapp, E. & Reichl, U.) 379–411 (Springer, 2021). * Yang, X. & Bartlett, M. G. _J. Chromatogr. B_

1120, 29–40 (2019). Article  CAS  Google Scholar  * Luo, S. & Zhang, B. _Pharm Res._ 41, 29–37 (2024). Article  CAS  PubMed  Google Scholar  * Luo, S. & Zhang, B. _mAbs_ 16, 2304268

(2024). Article  PubMed  PubMed Central  Google Scholar  * Schachner, L. F. et al. _Nat. Commun._ 15, 3259 (2024). Article  CAS  PubMed  PubMed Central  Google Scholar  Download references

AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Department of Cell Research and Immunology, The Shmunis School of Biomedicine and Cancer Research, The George S. Wise Faculty of Life Sciences,

Tel Aviv University, Tel Aviv, Israel Sharon Yehuda & Vered Padler-Karavani Authors * Sharon Yehuda View author publications You can also search for this author inPubMed Google Scholar *

Vered Padler-Karavani View author publications You can also search for this author inPubMed Google Scholar CORRESPONDING AUTHOR Correspondence to Vered Padler-Karavani. ETHICS DECLARATIONS

COMPETING INTERESTS The authors declare no competing interests. RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Yehuda, S., Padler-Karavani, V. Cracking

the diversity of sweet drugs. _Nat Chem Biol_ 20, 1397–1398 (2024). https://doi.org/10.1038/s41589-024-01755-6 Download citation * Published: 24 October 2024 * Issue Date: November 2024 *

DOI: https://doi.org/10.1038/s41589-024-01755-6 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is

not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative